Teladoc Health (STU:4LL) Cyclically Adjusted Revenue per Share: €11.60 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:4LL Teladoc Health Inc STU:4LL
58 GF Score
Price €5.47
GF Value €7.01
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Teladoc Health Cyclically Adjusted Revenue per Share?

Teladoc Health STU:4LL -0.55% 58 Cyclically Adjusted Revenue per Share is €11.60 as of Jun. 2026. GuruFocus rates STU:4LL with a GF Score™ of 58/100 and a GF Value™ of €7.01 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Teladoc Health's adjusted revenue per share for the three months ended in Jun. 2026 was €2.884. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €11.60 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Teladoc Health's average Cyclically Adjusted Revenue Growth Rate was 12.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-19), Teladoc Health's current stock price is €5.47. Teladoc Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €11.60. Teladoc Health's Cyclically Adjusted PS Ratio of today is 0.47.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Teladoc Health was 2.45. The lowest was 0.38. And the median was 0.76.


Teladoc Health  (STU:4LL) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Teladoc Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=5.47/11.596
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Teladoc Health was 2.45. The lowest was 0.38. And the median was 0.76.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Teladoc Health Cyclically Adjusted Revenue per Share Related Terms


Teladoc Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Teladoc Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teladoc Health Cyclically Adjusted Revenue per Share Chart

Teladoc Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.60 8.23 9.74 10.79

Teladoc Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.33 10.64 10.85 11.26 11.60

STU:4LL vs GDRX, CERT, OMDA: Cyclically Adjusted Revenue per Share Comparison

For the Health Information Services subindustry, Teladoc Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teladoc Health Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Teladoc Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Teladoc Health's Cyclically Adjusted PS Ratio falls into.


STU:4LL
58GF Score
Teladoc Health Inc STU:4LL
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teladoc Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Teladoc Health's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.884/333.9520*333.9520
=2.884

Current CPI (Jun. 2026) = 333.9520.

Teladoc Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.633 241.428 0.876
201612 0.753 241.432 1.042
201703 0.771 243.801 1.056
201706 0.743 244.955 1.013
201709 1.035 246.819 1.400
201712 1.122 246.524 1.520
201803 1.180 249.554 1.579
201806 1.260 251.989 1.670
201809 1.398 252.439 1.849
201812 1.531 251.233 2.035
201903 1.597 254.202 2.098
201906 1.617 256.143 2.108
201909 1.720 256.759 2.237
201912 1.948 256.974 2.532
202003 2.240 258.115 2.898
202006 2.861 257.797 3.706
202009 2.957 260.280 3.794
202012 2.506 260.474 3.213
202103 2.475 264.877 3.120
202106 2.676 271.696 3.289
202109 2.776 274.310 3.380
202112 3.032 278.802 3.632
202203 3.139 287.504 3.646
202206 3.444 296.311 3.881
202209 3.753 296.808 4.223
202212 3.857 296.797 4.340
202303 3.600 301.836 3.983
202306 3.651 305.109 3.996
202309 3.675 307.789 3.987
202312 3.700 306.746 4.028
202403 3.549 312.332 3.795
202406 3.505 314.175 3.726
202409 3.400 315.301 3.601
202412 3.476 315.605 3.678
202503 3.434 319.799 3.586
202506 3.169 322.561 3.281
202509 3.030 324.800 3.115
202512 3.103 324.054 3.198
202603 2.929 330.213 2.962
202606 2.884 333.952 2.884

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €11.60 mean?
Teladoc Health (STU:4LL) has a Cyclically Adjusted Revenue per Share of €11.60 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Teladoc Health and its competitors.
Is Teladoc Health's Cyclically Adjusted Revenue per Share too high?
Teladoc Health's current Cyclically Adjusted Revenue per Share is €11.60. Overall, Teladoc Health has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Teladoc Health's Cyclically Adjusted Revenue per Share compare to GDRX and CERT?
Teladoc Health's Cyclically Adjusted Revenue per Share of €11.60 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Teladoc Health and its competitors. Teladoc Health's current Cyclically Adjusted Revenue per Share is €11.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teladoc Health stock overvalued right now?
Based on GuruFocus' analysis, Teladoc Health (STU:4LL) is currently considered Modestly Undervalued. The stock's GF Value™ is €7.01, compared to a current price of €5.47 — trading 22% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €11.60. Teladoc Health's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Teladoc Health (STU:4LL), the current Cyclically Adjusted Revenue per Share is €11.60 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teladoc Health (STU:4LL) Overvalued in 2026?

Based on GuruFocus' analysis, Teladoc Health stock appears to be undervalued. The current stock price of €5.47 is trading 22% below its estimated GF Value™ of €7.01. GuruFocus considers Teladoc Health to be Modestly Undervalued.

Key valuation signals for STU:4LL:

  • Cyclically Adjusted Revenue per Share: €11.60
  • GF Value™: €7.01 vs. price of €5.47 (22% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the STU:4LL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Teladoc Health Business Description

Address 155 East 44th Street, Suite 1700, New York, NY, USA, 10017
Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.
58GF Score

Get the complete analysis for STU:4LL

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.47
Price
€7.01
GF Value